Ovarian cancer is one of the most serious cancers that affect women. It is known for being difficult to detect early and often causes very few symptoms at the beginning.
Because of this, many women are only diagnosed when the disease has already spread, making treatment much harder.
Around the world, ovarian cancer is one of the leading causes of cancer-related death in women. Many patients survive less than five years after diagnosis, which shows how urgent it is to find better ways to detect and treat this disease.
Among the different types of ovarian cancer, high-grade serous carcinoma is the most aggressive and dangerous form. For many years, scientists believed that this cancer started in the ovaries themselves.
However, more recent research has suggested that it may actually begin in another part of the body—the fallopian tubes, which connect the ovaries to the uterus. Even with this idea, researchers were not sure exactly how the cancer started or which cells were responsible.
Now, a new study published in Nature Communications has provided an important answer. The research was led by Dr. Alexander Nikitin from Cornell University’s College of Veterinary Medicine. His team has identified a specific group of cells in the fallopian tubes that are most likely the starting point of this deadly cancer.
These cells are called pre-ciliated tubal epithelial cells. To understand what this means, it helps to know a little about how cells develop. In the body, stem cells can turn into many different types of cells. As they develop, they go through several stages before becoming fully mature.
Pre-ciliated cells are in one of these middle stages. They are on their way to becoming ciliated cells, which have tiny hair-like structures called cilia. These cilia help move fluids and eggs through the fallopian tubes.
In the past, scientists thought that stem cells were the main source of cancer. But this new study shows something different. The researchers found that when important protective genes were turned off in stem cells, the cells did not become cancerous.
Instead, they simply died. However, when the same genes were turned off in pre-ciliated cells, these cells began to turn into cancer.
To study this process, the researchers used specially designed mice. They focused on two key genes known to protect against cancer, called TP53 and RB1. These genes are often damaged or missing in human cases of high-grade serous carcinoma.
In mice, the equivalent genes are called Trp53 and Rb1. When the scientists turned off these genes in different types of fallopian tube cells, only the pre-ciliated cells developed into cancer.
This finding is very important because it clearly points to the exact cell type where this cancer begins. It also helps scientists understand the process that leads to cancer development. The stage that these cells are in, known as ciliogenesis, has already been studied in detail. This gives researchers a clearer picture of when and how things start to go wrong.
The team also found that a gene called Krt5 is very active in these pre-ciliated cells. When they turned off the cancer-protecting genes in cells with high levels of Krt5, the mice quickly developed aggressive ovarian cancer. This confirms that these cells play a key role in starting the disease.
Although this study was done in mice, the structure of the fallopian tubes in mice is very similar to that in humans. This means the findings are likely to be relevant to people as well. However, more research is needed to confirm these results in human tissue.
This discovery opens up new possibilities for the future. If doctors can identify these pre-ciliated cells before they turn into cancer, it may be possible to detect ovarian cancer much earlier. Earlier detection could greatly improve survival rates.
In addition, scientists may be able to develop treatments that target this early stage of cell development, stopping cancer before it fully forms. Genes like Krt5 may also be used to create new screening tests to identify women at higher risk.
Dr. Nikitin and his team believe that this research could lead to more personalized care for patients. By understanding exactly where and how the cancer begins, doctors may one day be able to design treatments that are tailored to each person’s risk and condition. This could improve both survival and quality of life for many women.
While there is still more work to do, this study offers real hope. It brings scientists one step closer to solving a long-standing mystery and finding better ways to fight one of the most dangerous cancers affecting women today.
If you care about cancer, please read studies that artificial sweeteners are linked to higher cancer risk, and how drinking milk affects risks of heart disease and cancer.
For more health information, please see recent studies about the best time to take vitamins to prevent heart disease, and results showing vitamin D supplements strongly reduces cancer death.
Copyright © 2026 Knowridge Science Report. All rights reserved.
